“…The MDR methodology has been successfully applied to detecting gene-environment and gene-gene interactions for several clinical phenotypes, including: Alzheimer disease [12] , asthma [13,14] , atrial fibrillation [9,15] , myocardial infarction [16,17] , autism [18,19] , bladder cancer [20] , familial amyloid polyneuropathy [21] , hypertension [22,23] , multiple sclerosis [24] , prostate cancer [25] , schizophrenia [26] , sporadic breast cancer [10] , and type II diabetes [27] .…”